Literature DB >> 35585472

Impact of gastric and bowel surgery on gastrointestinal drug delivery.

Susan Hua1,2, Ephraem C Lye3,4.   

Abstract

General surgical procedures on the gastrointestinal tract are commonly performed worldwide. Surgical resections of the stomach, small intestine, or large intestine can have a significant impact on the anatomy and physiological environment of the gastrointestinal tract. These physiological changes can affect the effectiveness of orally administered formulations and drug absorption and, therefore, should be considered in rational drug formulation design for specific pathological conditions that are commonly associated with surgical intervention. For optimal drug delivery, it is important to understand how different surgical procedures affect the short-term and long-term functionality of the gastrointestinal tract. The significance of the surgical intervention is dependent on factors such as the specific region of resection, the degree of the resection, the adaptive and absorptive capacity of the remaining tissue, and the nature of the underlying disease. This review will focus on the common pathological conditions affecting the gastric and bowel regions that may require surgical intervention and the physiological impact of the surgery on gastrointestinal drug delivery. The pharmaceutical considerations for conventional and novel oral drug delivery approaches that may be impacted by general surgical procedures of the gastrointestinal tract will also be addressed.
© 2022. The Author(s).

Entities:  

Keywords:  Drug delivery; Gastric; Gastrointestinal; Nanomedicine; Small and large bowel; Surgery

Year:  2022        PMID: 35585472     DOI: 10.1007/s13346-022-01179-6

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  112 in total

Review 1.  Parietal cell vagotomy versus vagotomy-antrectomy: ulcer surgery in the modern era.

Authors:  P E Donahue
Journal:  World J Surg       Date:  2000-03       Impact factor: 3.352

Review 2.  Surgical treatment of peptic ulcer disease.

Authors:  A K Sachdeva; H A Zaren; B Sigel
Journal:  Med Clin North Am       Date:  1991-07       Impact factor: 5.456

Review 3.  A relic or still relevant: the narrowing role for vagotomy in the treatment of peptic ulcer disease.

Authors:  Janaka Lagoo; Theodore N Pappas; Alexander Perez
Journal:  Am J Surg       Date:  2013-10-16       Impact factor: 2.565

Review 4.  Control of gastric acid secretion in health and disease.

Authors:  Mitchell L Schubert; David A Peura
Journal:  Gastroenterology       Date:  2008-05-12       Impact factor: 22.682

Review 5.  Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.

Authors:  A B Shreya; Sushil Yadaorao Raut; Renuka Suresh Managuli; Nayanabhirama Udupa; Srinivas Mutalik
Journal:  AAPS PharmSciTech       Date:  2018-12-18       Impact factor: 3.246

6.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

Review 7.  All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance.

Authors:  Grace B Hatton; Christine M Madla; Sarit C Rabbie; Abdul W Basit
Journal:  Int J Pharm       Date:  2018-06-30       Impact factor: 5.875

Review 8.  Burden of Gastric Cancer.

Authors:  Aaron P Thrift; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-27       Impact factor: 11.382

Review 9.  Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

Review 10.  Physiological and Pharmaceutical Considerations for Rectal Drug Formulations.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2019-10-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.